SMAF - PRWeb Press Release Group http://www.rsspad.com/rss2/959.xml SMAF - Powered by PRWeb and RSSPad en xml@emediawire.com xml@emediawire.com 30 Boston Neurobiologist Receives Grant to Battle Leading Genetic Killer of Infants and Toddlers http://www.prweb.com/releases/2005/04/prweb223846.htm Funding to Support Further Study of Genetic Disease Impacting Infants.The recipient of this year’s Young Investigator Award in Spinal Muscular Atrophy (SMA) is Mustafa Sahin, MD, PhD, from Children’s Hospital Boston. Dr. Sahin, a neurobiologist specializing in child neurology, will conduct new research on SMA – the leading genetic killer of infants and toddlers and a disease which has no known treatment or cure. The Young Investigator Award was established in 2003 as an incentive and mentoring program that allows a new generation of scientists the opportunity to initiate innovative research projects to accelerate the development of a cure for SMA. (PRWeb Apr 1, 2005)

Read the full story at http://www.prweb.com/releases/2005/04/prweb223846.htm

]]> Fri, 01 Apr 2005 08:00:00 GMThttp://www.prweb.com/releases/2005/04/prweb223846.htm Prominent Researchers at Columbia University Receive Significant Funding to Combat Leading Genetic Killer of Infants and Toddlers http://www.prweb.com/releases/2005/03/prweb214571.htm With an estimated 55,000 people afflicted with the disease in the United States, Europe and Japan, spinal muscular atrophy, once among the least understood diseases in medicine, has recently emerged as one of the genetic conditions closest to a treatment. Researchers at Columbia University have received more than $3 million in funding from the Spinal Muscular Atrophy Foundation to conduct research on spinal muscular atrophy (SMA), a neuromuscular disease that is the leading genetic killer of infants and toddlers. The funding will enable the institution to significantly expand its already substantial SMA research. (PRWeb Mar 3, 2005)

Read the full story at http://www.prweb.com/releases/2005/03/prweb214571.htm

]]> Thu, 03 Mar 2005 08:00:00 GMThttp://www.prweb.com/releases/2005/03/prweb214571.htm Spinal Muscular Atrophy Foundation Funds Over $15 Million to Develop Treatments for the Leading Genetic Killer of Infants and Toddlers http://www.prweb.com/releases/2004/11/prweb183408.htm The Spinal Muscular Atrophy Foundation, a nonprofit organization dedicated to finding a treatment or cure for spinal muscular atrophy (SMA) – the leading genetic killer of infants and toddlers – announced that is has funded more than $15 million in research in the last 18 months. Projects were selected from a large pool of industry and academic investigators on the basis of scientific promise and potential to advance therapeutics development. The Foundation continues to seek out innovative and high quality research opportunities particularly those in the neuroscience biotechnology sector. (PRWeb Nov 29, 2004)

Read the full story at http://www.prweb.com/releases/2004/11/prweb183408.htm

]]> Mon, 29 Nov 2004 08:00:00 GMThttp://www.prweb.com/releases/2004/11/prweb183408.htm Jackson Laboratory to Distribute Mouse Models for Spinal Muscular Atrophy – the Leading Genetic Cause of Infant and Toddler Death http://www.prweb.com/releases/2004/10/prweb170285.htm Bar Harbor, Maine – October 21, 2004 – The Jackson Laboratory is pleased to announce that it has received support from the Spinal Muscular Atrophy Foundation to make available the first group of mouse models for spinal muscular atrophy (SMA), a neuromuscular disease and the leading genetic cause of death among infants and toddlers. The mice will be available to the scientific community from the Laboratory in the first half of 2005. (PRWeb Oct 21, 2004)

Read the full story at http://www.prweb.com/releases/2004/10/prweb170285.htm

]]> Thu, 21 Oct 2004 07:00:00 GMThttp://www.prweb.com/releases/2004/10/prweb170285.htm Spinal Muscular Atrophy Foundation Commits Up To$1 Million for Young Investigator Awards -- Foundation Seeks Researchers to Further Study Genetic Disease Impacting Infants http://www.prweb.com/releases/2004/05/prweb128926.htm The Spinal Muscular Atrophy Foundation, in partnership with the American Academy of Neurology Foundation, today announced that they are seeking grant applications from investigators working on innovative spinal muscular atrophy (SMA) research projects. The Foundations will provide up to $1 million in research grants through their Young Investigator Awards initiative, a program to encourage and facilitate research by emerging young stars. The value of each individual grant is more than $350,000. The initiative is designed to accelerate progress towards a cure for SMA, the leading genetic killer of infants and toddlers. (PRWeb May 25, 2004)

Read the full story at http://www.prweb.com/releases/2004/05/prweb128926.htm

]]> Tue, 25 May 2004 07:00:00 GMThttp://www.prweb.com/releases/2004/05/prweb128926.htm Loren Eng Testifies Before Congress For Support and Funding of Spinal Muscular Atrophy Research http://www.prweb.com/releases/2004/04/prweb122444.htm Loren Eng, Founder and President of the Spinal Muscular Atrophy Foundation, testified Tuesday, April 27th on Capitol Hill before the House Labor, Health, Human Services and Education Appropriations Subcommittee. Eng urged Congress for increased funding and support for the National Institute of Health (NIH) research programs on Spinal Muscular Atrophy (SMA), the leading genetic killer of infants and toddlers. (PRWeb Apr 29, 2004)

Read the full story at http://www.prweb.com/releases/2004/04/prweb122444.htm

]]> Thu, 29 Apr 2004 07:00:00 GMThttp://www.prweb.com/releases/2004/04/prweb122444.htm Spinal Muscular Atrophy Foundation Awards $1.125 Million In Grants To Support SMA Research Efforts -- Funding to Promote and Advance Clinical Research for the Cause, Treatment and Potential Cure for Spinal Muscular Atrophy http://www.prweb.com/releases/2004/04/prweb120308.htm The Spinal Muscular Atrophy Foundation announces that it has awarded new research grants totaling $1.125 million to four outstanding Young Investigators specializing in research on Spinal Muscular Atrophy (SMA), the leading genetic killer of infants and toddlers. These grants support the implementation and advancement of clinical research into the cause, treatment and potential cure for SMA. (PRWeb Apr 21, 2004)

Read the full story at http://www.prweb.com/releases/2004/04/prweb120308.htm

]]> Wed, 21 Apr 2004 07:00:00 GMThttp://www.prweb.com/releases/2004/04/prweb120308.htm